Ostizeel™ is a clinically formulated joint health supplement designed to reduce pain, control inflammation, and support cartilage protection through a science-backed, multi-pathway mechanism.
Ostizeel™ is a clinically formulated supplement designed for the comprehensive management of osteoarthritis. It helps reduce joint pain, inflammation, muscle weakness, and cartilage degradation.
Yes. It inhibits matrix metalloproteinases (MMPs), enzymes that break down cartilage, and helps preserve joint structure.
Yes. It is validated through multiple trials using global standards like WOMAC, VAS, and LFI to assess OA severity and treatment outcomes.
Clinical evidence shows pain relief may begin as early as Day 3. Continued use improves joint flexibility and mobility.
Ostizeel™ targets both nociceptive and neuropathic pain pathways while reducing inflammation and supporting muscle and cartilage protection.
While it is generally safe, consult your healthcare provider before combining Ostizeel™ with other treatments or prescriptions.
It contains Palmitoylethanolamide (PEA) and Cucumis sativus extract, which offer anti-inflammatory, analgesic, and chondroprotective benefits.
It supports joints commonly affected by OA, including the knees, hips, spine, hands, and feet.
The standard dosage is 1 sachet, tablet, or capsule once or twice daily, or as directed by your healthcare provider.
Ostizeel™ can be taken after meals with water. Consistency is key for optimal results.
Yes. Ostizeel™ is designed for global access and will be available for international supply and distribution (as per website or partner guidelines).
Yes. Both active ingredients have demonstrated safety in multiple clinical and preclinical studies. It is well tolerated in long-term use.